Zurich Cantonal Bank
VKTX icon

Zurich Cantonal Bank’s Viking Therapeutics VKTX Stock Holding History

Zurich Cantonal Bank’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
50,273
+3,487
+7% +$113K ﹤0.01% 1153
2026
Q1 		$1.52M Buy
46,786
+10,009
+27% +$322K ﹤0.01% 1187
2025
Q4 		$1.29M Buy
36,777
+968
+3% +$34.3K ﹤0.01% 1197
2025
Q3 		$941K Buy
35,809
+3,264
+10% +$97.4K ﹤0.01% 1325
2025
Q2 		$862K Buy
32,545
+2,099
+7% +$55.3K ﹤0.01% 1319
2025
Q1 		$735K Buy
30,446
+3,611
+13% +$114K ﹤0.01% 1366
2024
Q4 		$1.08M Buy
26,835
+4,012
+18% +$229K ﹤0.01% 1145
2024
Q3 		$1.44M Buy
22,823
+646
+3% +$37.9K ﹤0.01% 938
2024
Q2 		$1.18M Buy
22,177
+3,755
+20% +$246K ﹤0.01% 988
2024
Q1 		$1.51M Sell
18,422
-1,915
-9% -$85.2K 0.01% 862
2023
Q4 		$378K Buy
20,337
+3,698
+22% +$48.4K ﹤0.01% 1692
2023
Q3 		$184K Buy
16,639
+4,136
+33% +$59.2K ﹤0.01% 2019
2023
Q2 		$203K Buy
12,503
+3,420
+38% +$71.7K ﹤0.01% 1917
2023
Q1 		$151K Buy
+9,083
New +$93.8K ﹤0.01% 2051
2022
Q2 		– Sell
-20,294
Closed -$61K – 2933
2022
Q1 		$61K Hold
20,294
– – ﹤0.01% 2472
2021
Q4 		$93K Buy
20,294
+12,145
+149% +$68.1K ﹤0.01% 2552
2021
Q3 		$51K Hold
8,149
– – ﹤0.01% 2607
2021
Q2 		$49K Hold
8,149
– – ﹤0.01% 2454
2021
Q1 		$52K Hold
8,149
– – ﹤0.01% 2375
2020
Q4 		$46K Hold
8,149
– – ﹤0.01% 2456
2020
Q3 		$47K Hold
8,149
– – ﹤0.01% 2270
2020
Q2 		$59K Buy
8,149
+4,210
+107% +$28K ﹤0.01% 2161
2020
Q1 		$18K Hold
3,939
– – ﹤0.01% 2367
2019
Q4 		$32K Hold
3,939
– – ﹤0.01% 2357
2019
Q3 		$27K Hold
3,939
– – ﹤0.01% 2352
2019
Q2 		$33K Hold
3,939
– – ﹤0.01% 2286
2019
Q1 		$39K Hold
3,939
– – ﹤0.01% 2148
2018
Q4 		$30K Buy
+3,939
New +$47.1K ﹤0.01% 2300

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Zurich Cantonal Bank's VKTX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Viking Therapeutics (VKTX) stake by 7.5% in Q2 2026, buying an estimated $113K and bringing the position to 50,273 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Zurich Cantonal Bank first reported a position in VKTX in Q4 2018 and has held it in 28 quarters since. 434 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Zurich Cantonal Bank held 50,273 shares of Viking Therapeutics worth $1.96M as of Q2 2026.
  • Zurich Cantonal Bank bought 3,487 Viking Therapeutics shares in Q2 2026, an estimated $113K.
  • Viking Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1153 holding.
  • Zurich Cantonal Bank first reported a position in Viking Therapeutics in Q4 2018 and has held it in 28 quarters since.
  • 434 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.